Replies to post #673 on Javelin Pharmaceuticals Inc (JAV)

[Ronharv]

Well, prior boosters of today's FDA presentation (I'm assuming it's today) seem to have fizzled.

Re being acquired: Owner of close to 2 million shares is founder and president Dr. Fred Mermelstein. So while normally I dismiss talk of small stocks I own being bought out (posters always speculate about this), Javelin happens to be the 12th venture-capital firm started by Fred, who's a serial builder and seller of companies. Javelin is easily the biggest yet, so the likelihood of an ultimate buyout isn't half bad. . . but not until the company gains commercial traction and, with it, a price smartly superior to what JAV's trading at now. So my guess is that the best buyout opportunity is 12 to 18 months away.